Abstract:Heparins have been invaluable therapeutic anticoagulant polysaccharides for over a century, whether used as unfractionated heparin or as low molecular weight heparin (LMWH) derivatives. However, heparin production by extraction from animal tissues presents multiple challenges, including the risk of adulteration, contamination, prion and viral impurities, limited supply, insecure supply chain, and significant batch-to-batch variability. The use of animal-derived heparin also raises ethical and religious concerns, as well as carries the risk of transmitting zoonotic diseases. Chemoenzymatic synthesis of animal-free heparin products would offer several advantages, including reliable and scalable production processes, improved purity and consistency, and the ability to produce heparin polysaccharides with molecular weight, structural, and functional properties equivalent to those of the United States Pharmacopeia (USP) heparin, currently only sourced from porcine intestinal mucosa. We report a scalable process for the production of bioengineered heparin that is biologically and compositionally similar to USP heparin. This process relies on enzymes from the heparin biosynthetic pathway, immobilized on an inert support and requires a tailored N-sulfoheparosan with N-sulfo levels similar to those of porcine heparins. We also report the conversion of our bioengineered heparin into a LMWH that is biologically and compositionally similar to USP enoxaparin. Ultimately, we demonstrate major advances to a process to provide a potential clinical and sustainable alternative to porcine-derived heparin products.

Using Engineered 6-O-sulfotransferase to Improve the Synthesis of Anticoagulant Heparin

Synthesis of 3- O-Sulfated Heparan Sulfate Oligosaccharides Using 3- O-Sulfotransferase Isoform 4

Biosynthetic production of anticoagulant heparin polysaccharides through metabolic and sulfotransferases engineering strategies

Synthesis of 3-O-sulfated Oligosaccharides to Understand the Relationship Between Structures and Functions of Heparan Sulfate.

Bioengineered Chinese Hamster Ovary Cells with Golgi-Targeted 3-O-sulfotransferase-1 Biosynthesize Heparan Sulfate with an Antithrombin-Binding Site

Chemoenzymatic synthesis of heparan sulfate and heparin

Immobilized Enzymes to Convert N-sulfo, N-acetyl Heparosan to a Critical Intermediate in the Production of Bioengineered Heparin

Expression of heparan sulfate sulfotransferases in Kluyveromyces lactis and preparation of 3'-phosphoadenosine-5'-phosphosulfate.

Understanding the Substrate Specificity of the Heparan Sulfate Sulfotransferases by an Integrated Biosynthetic and Crystallographic Approach

High cell density cultivation of a recombinant Escherichia coli strain expressing a 6-O-sulfotransferase for the production of bioengineered heparin.

Chemoenzymatic Synthesis of Unmodified Heparin Oligosaccharides: Cleavage of P-Nitrophenyl Glucuronide by Alkaline and Smith Degradation

Chemical O-sulfation of N-sulfoheparosan: a Route to Rare N-sulfo-3-O-sulfoglucosamine and 2-O-sulfoglucuronic Acid.

High Cell Density Cultivation of Recombinant Escherichia coli Strains Expressing 2- O -Sulfotransferase and C5-Epimerase for the Production of Bioengineered Heparin

CHAPTER 8. Chemoenzymatic Synthesis of Low-Molecular-Weight Heparin and Heparan Sulfate

Combinatorial One-Pot Chemoenzymatic Synthesis of Heparin.

Chemoenzymatic Synthesis of Heparan Sulfate Tetrasaccharide from a N-acetyl-α-d-glucosamine-O-methylglycoside Acceptor

Nanopore-regulated in situ polymerization for synthesis of homogeneous heparan sulfate with low dispersity

Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparin

Chemoenzymatic Synthesis of Heparan Sulfate and Heparin Oligosaccharides and NMR Analysis: Paving the Way to a Diverse Library for Glycobiologists

Recent Advances in the Synthesis of Heparan Sulfate Oligosaccharides

Preparation and structural characterization of a sulfated octasaccharide with heparin-like anticoagulant activity